Study Suggests That Kidney Disease Researchers Aren’t Considering Patient-Focused Outcomes
source: pixabay.com

Study Suggests That Kidney Disease Researchers Aren’t Considering Patient-Focused Outcomes

According to a story from PR Newswire, a recent study indicated that researchers that were focused on kidney illnesses such as chronic kidney disease, congenital nephrotic syndrome, and glomerulonephritis have not been…

Continue Reading Study Suggests That Kidney Disease Researchers Aren’t Considering Patient-Focused Outcomes
Living with Hereditary Angiodema: My Life was Changed in an Instant, Part One
Source: Loukisha Olive-McCoy

Living with Hereditary Angiodema: My Life was Changed in an Instant, Part One

From birth until my mid-thirties I was a very active person. I loved dancing West Coast Swing, doing yoga, and cooking large meals for my ‘Ohana. The word "'Ohana" describes…

Continue Reading Living with Hereditary Angiodema: My Life was Changed in an Instant, Part One
ICYMI: New Investigational Treatment Could be a Step Forward Against Graft-versus-Host Disease
source: pixabay.com

ICYMI: New Investigational Treatment Could be a Step Forward Against Graft-versus-Host Disease

According to a story from Financial Buzz, the pharmaceutical company Elsayls Biotech is planning to submit a proposal to the European Medicines Agency (EMA) in order to conduct a clinical…

Continue Reading ICYMI: New Investigational Treatment Could be a Step Forward Against Graft-versus-Host Disease
Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results
Source: Pixabay

Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results

The phase 3 trial of the drug Inlyta for the treatment of patients with a high risk of recurrent renal cell carcinoma (kidney cancer) following nephrectomy (removal of a kidney)…

Continue Reading Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results
A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy
source: pixabay.com

A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy

According to a story from statnews.com, a drug derived from substances originating in the cannabis plant may be nearing approval by the U.S. Food and Drug Administration. The drug is…

Continue Reading A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy
Devan Demmons and Service Dog Duke Make Pageant History while Raising Awareness about Dysautonomia
source: pixabay.com

Devan Demmons and Service Dog Duke Make Pageant History while Raising Awareness about Dysautonomia

The 2018 Mrs. Maine International Pageant will be so much more than a celebration of poise and beauty. It will also make history when Devan Demmons will proudly walk on…

Continue Reading Devan Demmons and Service Dog Duke Make Pageant History while Raising Awareness about Dysautonomia
Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions
1041483 / Pixabay

Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions

Scientists are investigating whether delaying the onset of epilepsy in very young children could reduce or prevent other neurological conditions such as learning difficulties and autism, reports Medical Xpress. This…

Continue Reading Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions